Dr. Greg Vigna Debridement for decubitus ulcers must align with treatment goals, with early reconstructive surgery recommended to avoid ris ...

MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...

surgical debridement products, and ultrasonic debridement systems mechanical debridement products segment leads the market. By wound type, the global market is segmented into burns, diabetic foot ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, for treating venous leg ulcers (VLUs). The primary aim of the trial is to ...

Ohio Valley Surgical Hospital has opened up a new Wound and Hyperbaric Center in Springfield. The new center, which opened last week at 100 W. Main St. on the second floor, is part of an effort to ...

Austin House, the brainchild of Shirantha Peries, founder of the Mega Pharma group of companies, will be extending his considerably extensive portfolio when he opens the doors of the Austin House ...

The rationale for the study was anecdotal reports of the effects of breast milk used by mothers to treat blocked tear ducts, ...